Shergill Bav, Zokaie Simon, Carr Alison J
Department of Dermatology, Brighton and Sussex University Hospitals, Elm Grove, Brighton, UK.
Leo Pharma, Princes Risborough, London, UK.
Patient Prefer Adherence. 2013 Dec 17;8:35-41. doi: 10.2147/PPA.S47126. eCollection 2013.
There is limited information on the patterns of use, adherence rates, and factors that impact adherence with topical treatments for actinic keratosis (AK).
To establish patterns of use and adherence with topical treatments for AK and to identify treatment-related factors that impact on adherence.
A community-based, cross-sectional study was performed using a standardized questionnaire completed online or via telephone interview. Patients were stratified according to the presence of AK lesions on the scalp and/or other extremities; and presence of scarring resulting from treatment.
This study included 305 patients with AK who were currently using a patient-applied topical therapy for AK or had used one within the previous 12 months. In total, 88% (n = 268/305) of patients were either non-adherent, non-persistent or both non-adherent and non-persistent to topical therapy. Duration of treatment was associated with increasing rates of non-adherence (adjusted odds ratio [OR]; for treatment durations greater than 4 weeks, 2.2, P < 0.01): 52% of patients were non-adherent with 3-4 week treatment duration; 69% of patients with 4-8 week treatment duration; and 71% of patients with 6-12 week treatment duration. There were similar increases in non-persistence with increasing treatment duration (adjusted OR; for treatment durations greater than 4 weeks, 2.1, P < 0.05).
This study found high rates of non-adherence and non-persistence in patients with AK. Duration of treatment was a significant factor contributing to non-adherence and non-persistence to topical treatments. Patient-applied topical therapies that require less frequent application and have shorter treatment duration may be associated with improved adherence rates.
关于光化性角化病(AK)局部治疗的使用模式、依从率以及影响依从性的因素,相关信息有限。
确定AK局部治疗的使用模式和依从性,并识别影响依从性的治疗相关因素。
采用基于社区的横断面研究,通过在线完成或电话访谈的标准化问卷进行。患者根据头皮和/或其他肢体上AK病变的存在情况以及治疗导致的瘢痕形成情况进行分层。
本研究纳入了305例AK患者,这些患者目前正在使用患者自行涂抹的AK局部治疗药物,或在过去12个月内使用过一种。总体而言,88%(n = 268/305)的患者对局部治疗不依从、未坚持治疗或两者皆有。治疗持续时间与不依从率增加相关(调整后的优势比[OR];治疗持续时间大于4周时,为2.2,P < 0.01):治疗持续3 - 4周的患者中有52%不依从;治疗持续4 - 8周的患者中有69%;治疗持续6 - 12周的患者中有71%。随着治疗持续时间增加,未坚持治疗的情况也有类似增加(调整后的OR;治疗持续时间大于4周时,为2.1,P < 0.05)。
本研究发现AK患者中不依从和未坚持治疗的发生率很高。治疗持续时间是导致局部治疗不依从和未坚持治疗的一个重要因素。使用频率较低且治疗持续时间较短的患者自行涂抹的局部治疗药物可能与更高的依从率相关。